225 related articles for article (PubMed ID: 9681086)
1. Veno-occlusive disease of the liver induced by gemcitabine.
Dobbie M; Hofer S; Oberholzer M; Herrmann R
Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086
[No Abstract] [Full Text] [Related]
2. Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.
Vansteenkiste JF; Bomans P; Verbeken EK; Nackaerts KL; Demedts MG
Lung Cancer; 2001 Jan; 31(1):83-5. PubMed ID: 11162870
[No Abstract] [Full Text] [Related]
3. Hemolytic-uremic syndrome caused by gemcitabine.
Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
[No Abstract] [Full Text] [Related]
4. Gemcitabine for lung cancer.
Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
[No Abstract] [Full Text] [Related]
5. Gemcitabine and vascular toxicity.
Muñoz A; Mañé JM; Rubio I; Fernández R; Fuente N; Barceló R; López Vivanco G
Lung Cancer; 2002 Aug; 37(2):229. PubMed ID: 12140148
[No Abstract] [Full Text] [Related]
6. An unusual case of gemcitabine-induced radiation recall.
Squire S; Chan M; Feller E; Mega A; Gold R
Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
[No Abstract] [Full Text] [Related]
7. A fatal case of cholestatic liver failure probably related to gemcitabine.
Coeman DC; Verbeken EK; Nackaerts KL; Demedts MG; Vansteenkiste JF
Ann Oncol; 2000 Nov; 11(11):1503. PubMed ID: 11142494
[No Abstract] [Full Text] [Related]
8. Gemcitabine hydrochloride: combination of activity and tolerability. Proceedings of a symposium. Jerusalem, Israel, November 14, 1993.
Anticancer Drugs; 1995 Dec; 6 Suppl 6():5-65. PubMed ID: 8718418
[No Abstract] [Full Text] [Related]
9. [Severe interstitial pneumonitis related to Gemcitabine].
Sabria-Trias J; Bonnaud F; Sioniac M
Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
[TBL] [Abstract][Full Text] [Related]
10. Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy.
Banach MJ; Williams GA
Arch Ophthalmol; 2000 May; 118(5):726-7. PubMed ID: 10815173
[No Abstract] [Full Text] [Related]
11. Gemcitabine--a major advance?
Thomas A; Steward WP
Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
[No Abstract] [Full Text] [Related]
12. Vasculitis due to gemcitabine.
Voorburg AM; van Beek FT; Slee PH; Seldenrijk CA; Schramel FM
Lung Cancer; 2002 May; 36(2):203-5. PubMed ID: 11955656
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine-associated autonomic neuropathy.
Dormann AJ; Grünewald T; Wigginghaus B; Huchzermeyer H
Lancet; 1998 Feb; 351(9103):644. PubMed ID: 9500323
[No Abstract] [Full Text] [Related]
14. Maculopapular rashes secondary to gemcitabine injection for non-small-cell lung cancer.
Chen YM; Liu JM; Tsai CM; Whang-Peng J; Perng RP
J Clin Oncol; 1996 May; 14(5):1743-4. PubMed ID: 8622097
[No Abstract] [Full Text] [Related]
15. [The medical treatment of advanced non-small-cell lung carcinoma (adv NSCLC). The correlation with multidimensional assessment].
Guidi F; Paggi P; Lo Nardo D; Gattafoni P; Consales D
Minerva Med; 1999; 90(7-8):210-3. PubMed ID: 10719420
[No Abstract] [Full Text] [Related]
16. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer.
Lund B; Ryberg M; Petersen PM; Anderson H; Thatcher N; Dombernowsky P
Ann Oncol; 1994 Nov; 5(9):852-3. PubMed ID: 7848889
[No Abstract] [Full Text] [Related]
17. Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer.
Yildiz R; Coskun U; Kaya AO; Ozturk B; Yaman E
Ann Pharmacother; 2007 May; 41(5):901-2. PubMed ID: 17405819
[No Abstract] [Full Text] [Related]
18. [First-line non-small-cell lung cancer: role of gemcitabine].
Barata F
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S20-2. PubMed ID: 16273006
[No Abstract] [Full Text] [Related]
19. Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy.
Gurumurthy M; Koh P; Singh R; Bhide A; Satodia P; Hocking M; Anbarasu A; Wood LE
J Perinatol; 2009 Jan; 29(1):63-5. PubMed ID: 19112460
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine-induced hemolytic uremic syndrome: a case report.
Brodowicz T; Breiteneder S; Wiltschke C; Zielinski CC
J Natl Cancer Inst; 1997 Dec; 89(24):1895-6. PubMed ID: 9414181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
